Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00223223
Status:
COMPLETED
Last Update Posted:
2011-08-03
First Post:
2005-09-14
Brief Title:
Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction A Proof of Concept Study
Sponsor:
University of Texas Southwestern Medical Center
Organization:
University of Texas Southwestern Medical Center
Study Overview
Official Title:
Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction A Proof of Concept Study
Status:
COMPLETED
Status Verified Date:
2005-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research is to determine whether the memory impairment and manic symptoms feelings of agitation overexcitement or hyperactivity typically seen in those on corticosteroid therapy is decreased with a seizure medication called levetiracetam compared to placebo an inactive substance Since increased levels of cortisol the bodys natural corticosteroid in the body are frequently associated with memory impairment interventions that may prevent or reverse this are of great importance
It is hypothesized that patients who are scheduled to receive prescription corticosteroid therapy who are given levetiracetam pretreatment will show lesser memory impairment and manic symptoms than those receiving placebo
It is hypothesized that patients who are scheduled to receive prescription corticosteroid therapy who are given levetiracetam pretreatment will show lesser memory impairment and manic symptoms than those receiving placebo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None